Delving into the Latest Updates on Synthetic Vaccine Biotech Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Immune System Diseases

Infectious Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	1
Immune System Diseases	1
Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

TLR8(Toll like receptor 8)	1
TLR7 x TLR8	1

主要目的 1. 评价SV-1993胶囊在晚期实体瘤患者中的安全性和耐受性。 2. 确定扩展推荐剂量（RDE）和/或2期推荐剂量（RP2D）。 3. 观察可能出现的SV-1993胶囊的剂量限制性毒性（DLT）。 4. 确定最大耐受剂量（MTD）。次要目的 1. 评价SV-1993胶囊在晚期实体瘤患者中的药代动力学特征。 2. 评价SV-1993胶囊的初步抗肿瘤疗效。探索性目的 1. 评价SV-1993胶囊在晚期实体瘤患者中的生物标志物特征。 2. 评价SV-1993胶囊在晚期实体瘤患者中的药代动力学（PK）/药效动力学（PD）特征。

[Translation]

Primary Objectives: 1. To evaluate the safety and tolerability of SV-1993 capsules in patients with advanced solid tumors. 2. To determine the extended recommended dose (RDE) and/or the phase 2 recommended dose (RP2D). 3. To observe potential dose-limiting toxicities (DLTs) of SV-1993 capsules. 4. To determine the maximum tolerated dose (MTD). Secondary Objectives: 1. To evaluate the pharmacokinetic characteristics of SV-1993 capsules in patients with advanced solid tumors. 2. To evaluate the preliminary antitumor efficacy of SV-1993 capsules. Exploratory Objectives: 1. To evaluate the biomarker characteristics of SV-1993 capsules in patients with advanced solid tumors. 2. To evaluate the pharmacokinetic (PK)/pharmacodynamic (PD) characteristics of SV-1993 capsules in patients with advanced solid tumors.

Start Date-

Sponsor / Collaborator

Synthetic Vaccine Biotech Co., Ltd.

100 Clinical Results associated with Synthetic Vaccine Biotech Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Synthetic Vaccine Biotech Co., Ltd.

Login to view more data

100 Deals associated with Synthetic Vaccine Biotech Co., Ltd.

Login to view more data

100 Translational Medicine associated with Synthetic Vaccine Biotech Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Apr 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

1

Phase 1

Login to view more data